Glioblastoma

• Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patients Pending
  2024-514144-85-02 3
• An open-label dose escalation study to estimate maximum tolerated dose (MTD), identify dose-limiting toxicities (DLTs) and study pharmacokin … Pending
  2024-515128-35-00 1
• First study evaluating the safety and dosage of YG-01 in patients with a malignant brain tumor Pending
  2025-524299-44-00 1
• A study to investigate how a single dose of the drug melflufen reaches brain tumor tissue, and how it affects the tumour, in patients who ar … Recruiting
  2026-525543-32-00 3 2026-06-17 "Recurrent glioblastoma"
• A prospective randomized open-label phase II clinical study evaluating the efficacy and safety of zoledronic acid addition to standard thera … Recruiting
  2024-519446-67-00 4 2025-03-06
• A Phase III Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients with Recurrent Glioblastoma Recruiting
  2025-521785-10-00 5 2026-03-04
• Early-stage clinical trial investigating the individual and combined effect of two drugs, senicapoc and perampanel, as part of the treatment … Recruiting
  2025-522605-37-00 3 2026-03-01
• Itraconazole (ITRA) with standard radiotherapy (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma multiforme (GBM) IT … Recruiting
  2024-519239-40-01 3 2025-04-07 "Glioblastom"
• A study in newly diagnosed glioblastoma patients that aims at testing the efficacy of Optune (Tumor Treating Fields), together with temozolo … Recruiting
  2024-513550-30-00 5 2025-03-28 "Newly diagnosed Glioblastoma"
• Anti-GD2 ADC M3554 in Advanced Solid Tumors Recruiting
  2024-513687-26-00 1 2025-02-25 "Advanced Solid Tumors"
• A phase IB clinical trial on neoadjuvant and intraoperative intracranial administration of triple immune checkpoint blockade plus myeloid d … Recruiting
  2024-517842-33-01 3 2024-11-20 "glioblastoma"
• PRIDE – PRotective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma Recruiting
  2024-514865-20-00 4 2024-04-10
• ​​Lomustine with or without a second round of brain radiation for the reappearance of glioblastoma Recruiting
  2023-505267-36-00 5 2024-03-15
• Clinical and translational controlled study of Perampanel treatment around Surgery in patients with progressive glioblastoma (PerSurge) Recruiting
  2023-503938-52-00 4 2024-01-26 "Progressive Glioblastoma"
• A Study of Debio 0123 in Combination with Temozolomide in Adult Participants with Recurrent or Progressive Glioblastoma and of Debio 0123 in … Recruiting
  2022-502156-31-00 9 2023-05-26
• MIRROR; Multispectral and bimodal fluorescent guided surgery (FGS) of high-grade glioma for refining margin assessment: A phase 1 dose findi … Recruiting
  2024-513392-40-01 1 2023-03-31
• Individualized Systems Medicine strategy to target cancer stem cells in patients with recurrent Glioblastoma (ISM-GBM) Recruiting
  2023-510214-11-00 3 2023-03-21 "Recurrent Glioblastoma"
• Phase I trial evaluating the tolerance of repeated opening of the bloodbrain barrier by ultrasound before chemotherapy in the treatment of r … Recruiting
  2024-516169-35-00 7 2023-02-06 "recurrent primary supratentorial malignant brain tumors in c"
• Phase I/II dose escalation trial of radiodynamic therapy (RDT) with 5-Aminolevulinic acid in patients with first recurrence of glioblastoma Recruiting
  2024-517651-12-00 9 2022-10-28 "recurrent glioblastoma"
• Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy (MecMeth/ NOA-24) Recruiting
  2024-511264-89-00 4 2022-04-11
• Vaccination with Autologous Dendritic cells loaded with Autologous Tumour homogenate in Glioblastoma: a phase II Study Recruiting
  2024-512493-98-00 4 2021-03-25
• Glioblastoma treatment with irradiation and olaptesed pegol (NOX-A12) in unmethylated patients Recruiting
  2024-510964-21-00 9 2019-09-12
• Study to evaluate the therapeutic effect of a cell based immune therapy targeting cancer stem cells i the malignant brain tumor glioblastoma … Recruiting
  2024-518663-35-00 10 2018-04-25
• A randomized, open-label, multicentric, two-arm pivotal trial of SonoCloud-9 combined with carboplatin (CBDCA) vs standard of care lomustine … Recruitment ended
  2023-505829-14-00 5 2026-06-02 "First recurrence glioblastoma"

Showing 1–24 of 45 trials